Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


Salewski, E. (1964) Färbemethoden Zum Makroskopischen Nachweis von Implantationsstellen am Uterus der Ratte. Naunyn-Schmiedeberg’s Archivesof Pharmacology, 247, 367. http://dx.doi.org/10.1007/BF02308461

has been cited by the following article:

  • TITLE: Effects of Copaiba Oil on Cyclophosphamide-Induced Teratogenesis in Mice

    AUTHORS: Ana Carolina dos Santos Lourenço, José Eduardo Baroneza, Solange de Paula Ramos, Liliane Kelen Miguel, Luiz Carlos Juliani, Aline Pic-Taylor, Maria José Sparça Salles

    KEYWORDS: Copaiba Oil, Cyclophosphamide, Teratogenicity, Phytotherapy, Malformations

    JOURNAL NAME: American Journal of Plant Sciences, Vol.5 No.23, November 27, 2014

    ABSTRACT: Cyclophosphamide is an anti-neoplastic chemotherapy drug which, when administered to animals during the gestational period, provokes visceral, skeletal and external malformations. Copaiba oil obtained from Copaifera L. genus is traditionally used in popular medicine for its anti-inflammatory and antimicrobial activities. However, the effect of copaiba oil onteratogenesis remains unknown. This study aimed to investigate the possible protector effects of copaiba oil on the model of teratogenesis induced by cyclophosphamide in mice. Pregnant female Swiss mice were divided into 8 groups (n = 15). Three groups received copaiba oil, via gavage, in the following doses: 0.3 mL·Kg-1, 0.6 mL·Kg-1 and 0.9 mL·Kg-1 (b.w.), associated to phosphate-buffered saline (PBS), intraperitoneal (i.p.). The negative control group received medium chain triglyceride (MCT) and PBS. The positive control group received cyclophosphamide (30 mg·Kg-1 (b.w.)) and MCT. The three treatment groups called associated groups (A) received one of the doses of copaiba oil, via gavage and an associated dose of cyclophosphamide intraperitoneally. Copaiba oil presented a protective effect against teratogenesis induced by cyclophosphamide in the following skeletal structures: metacarpals, forepaws proximal phalanges, and tail vertebras. It also reduced the hydrocephalus frequency. These data suggest that copaiba oil could be a potential candidate for an anti-teratogenic agent.